Clinical Considerations Disease-Associated Maternal and/or Embryo-Fetal Risk Poorly controlled diabetes in pregnancy increases the maternal risk for diabetic ketoacidosis, preeclampsia, spontaneous abortions, preterm delivery, and delivery complications
We offer no guidance regarding administration, dosing, or reconstitution for purposes other than research
Those focused on skin, collagen and antioxidant protection
PMID: 41 SchmidDADeptaJPPichlerWJ
[12] Monitoring and patient safety advice: Patients should be monitored regularly during treatment, with assessment of: Weight and BMI Metabolic parameters (fasting glucose, HbA1c, lipid profile) Menstrual cycle patterns Symptoms of adverse effects When to contact your GP: Patients should seek medical advice if they experience severe or persistent abdominal pain, signs of pancreatitis, symptoms of gallbladder disease, unexplained neck lumps, significant mood changes, or if they suspect pregnancy
At 8mg or 12mg weekly, the injection volume exceeds what a standard 1mL insulin syringe can hold
